Preview

Creative surgery and oncology

Advanced search

Clinical Case of Successful Surgical Treatment for Giant Cell Metastatic Lung Sarcoma

https://doi.org/10.24060/2076-3093-2022-12-3-250-255

Abstract

Introduction. Sarcomas refer to a group of heterogeneous non-epithelial malignant tumors originating from connective tissue. These tumors are characterized by extremely aggressive local growth, relatively low incidence of lymphogenic metastases, predominant and early hematogenic generalization. These tumors most oft en metastasize to the lungs.

Materials and methods. The paper describes a case of successful surgical treatment for a giant retroperitoneal fibrosarcoma metastasis to the lung.

Results. Successful treatment for sarcoma depends primarily on a global understanding by oncologists of the complex pathogenesis, histological forms and principles of comprehensive treatment for this complex, polymorphic group of malignant pathologies. The earlier the primary site is diagnosed, the sooner and more definitely the surgical treatment is performed, and the more correctly the drug therapy is carried out, the better the result of the complex treatment approach. Similarly, sarcoma secondary sites should be treated proactively – without waiting until their size and local spread contraindicate surgical treatment. Conclusion. Neglected sarcoma cases indicate the need for combined and extended surgical interventions, one successful example of which is described in this paper.

About the Authors

G. A. Baksiyan
A.I. Burnazyan Federal Medical Biophysical Center FMBA; Medical and Biological School of Innovation and Continuous Education, A.I. Burnazyan Federal Medical Biophysical Center FMBA
Russian Federation

Oncological Surgery Unit, Department of Oncology and
Radiation Medicine with a course of Medical Physics

Moscow



N. G. Stepanyants
A.I. Burnazyan Federal Medical Biophysical Center FMBA; Medical and Biological School of Innovation and Continuous Education, A.I. Burnazyan Federal Medical Biophysical Center FMBA
Russian Federation

Cand. Sci. (Med.), Oncological Surgery Unit, Department of
Oncology and Radiation Medicine with a course of Medical

Moscow



D. N. Astakhov
A.I. Burnazyan Federal Medical Biophysical Center FMBA; Medical and Biological School of Innovation and Continuous Education, A.I. Burnazyan Federal Medical Biophysical Center FMBA
Russian Federation

Cand. Sci. (Med.), Oncological Surgery Unit, Department of Oncology and Radiation Medicine with a course of Medical Physics

Moscow



A. V. Aksenenko
A.I. Burnazyan Federal Medical Biophysical Center FMBA
Russian Federation

Cand. Sci. (Med.), Oncological Surgery Unit

Moscow



A. A. Zavyalov
A.I. Burnazyan Federal Medical Biophysical Center FMBA; Medical and Biological School of Innovation and Continuous Education, A.I. Burnazyan Federal Medical Biophysical Center FMBA
Russian Federation

Dr.Sci. (Med.), Professor, Oncology Center, Department of Oncology and Radiation Medicine with a course of Medical Physics

Moscow



References

1. Kaprin A.D., Starinsky V.V., Petrova G.V. (ed.) Malignant neoplasms in Russia in 2017. M.: P.A Gertsen Moscow Research Oncology Institute — branch of the National Medical Research Center for Radiology; 2018. 250 p. (In Russ.).

2. Arora R.D., Shaikh H. Osteogenic Sarcoma. 2022 Jun 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. PMID: 33085324

3. Ye C., Dai M., Zhang B. Risk factors for metastasis at initial diagnosis with Ewing sarcoma. Front Oncol. 2019;9:1043. DOI: 10.3389/fonc.2019.01043

4. Sasi A., Ganguly S., Biswas B., Pushpam D., Kumar A., Agarwala S., et al. Development and validation of a prognostic score at baseline diagnosis for Ewing sarcoma family of tumors: a retrospective single institution analysis of 860 patients. Am J Transl Res. 2022;14(2):927–41. PMID: 35273696

5. Li W., Zhang S. Survival of patients with primary osteosarcoma and lung metastases. J Buon. 2018;23(5):1500–4. PMID: 30570878

6. Huang X., Zhao J., Bai J., Shen H., Zhang B., Deng L., et al. Risk and clinicopathological features of osteosarcoma metastasis to the lung: A population-base d study. J Bone Oncol. 2019;16:100230. DOI: 10.1016/j.jbo.2019.100230

7. Wan L., Tu C., Qi L., Li Z. Survivorship and prognostic factors for pleomorphic liposarcoma: a population-based study. J Orthop Surg Res. 2021;16(1):175. DOI: 10.1186/s13018-021-02327-3

8. Gusho C.A., Fice M.P., O’Donoghue C.M., Gitelis S., Blank A.T. A Population-based analysis of lymph node metastasis in extremity soft tissue sarcoma: an update. J Surg Res. 2021;262:121–9. DOI: 10.1016/j.jss.2021.01.005

9. Outani H., Imura Y., Tanaka T., Takenaka S., Oshima K., Hamada K., et al. Clinical outcomes of patients with epithelioid sarcomas: impact and management of nodal metastasis. Int J Clin Oncol. 2018;23(1):181–8. DOI: 10.1007/s10147-017-1179-x

10. Stork T., Boemans R., Hardes J., Streitbürger A., Dirksen U., Pöttgen C., et al. Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma. BMC Cancer. 2021;21(1):375. DOI: 10.1186/s12885-021-08073-3

11. Knebel C., Lenze U., Pohlig F., Lenze F., Harrasser N., Suren C., et al. Prognostic factors and outcome of Liposarcoma patients: a retrospective evaluation over 15 years. BMC Cancer. 2017;17(1):410. DOI: 10.1186/s12885-017-3398-y

12. Wan L., Tu C., Qi L., Li Z. Survivorship and prognostic factors for pleomorphic liposarcoma: a population-based study. J Orthop Surg Res. 2021;16(1):175. DOI: 10.1186/s13018-021-02327-3

13. Chissov V.I., Trakhtenberg A. Kh., Parshin V.D., Likin O.V. Surgery of sarcoma metastases to the lungs. Russian Journal of Oncology. 2005;5:4–7 (In Russ.).

14. Smolenov E.I., Ragulin Yu.A., Starodubtsev A.L., Kuril’chik A.A., Ivanov V.E., Zubarev A.L. Surgical treatment of multiple lung metastasis in patient with soft issue and visceral sarcomas. Siberian Journal of Oncology. 2015;1(3):45–50 (In Russ.).


Review

For citations:


Baksiyan G.A., Stepanyants N.G., Astakhov D.N., Aksenenko A.V., Zavyalov A.A. Clinical Case of Successful Surgical Treatment for Giant Cell Metastatic Lung Sarcoma. Creative surgery and oncology. 2022;12(3):250-255. (In Russ.) https://doi.org/10.24060/2076-3093-2022-12-3-250-255

Views: 1012


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2076-3093 (Print)
ISSN 2307-0501 (Online)